#canaccord
Latest news and interesting information about canaccord.
Canaccord Initiates Rare Earths Americas with Buy
Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.
Kalshi hires former FBI analyst Neff for surveillance
Kalshi hires former FBI analyst Tyler Neff to bolster surveillance against insider trading in prediction markets.
Hinge Health president sells $860,605 in stock
Hinge Health president James Pursley sold 16,000 shares worth $860,605. Stock up 27% over the past year.
Ezcorp director Appel sells $499,980 in stock
EZCORP director Matthew Appel sold nearly $500K in stock. Company shows strong financial results and analyst support.
Strategy CFO sells $927,865 in shares
Strategy CFO Andrew Kang sold $927,865 worth of shares. The sale was related to RSU vesting and tax obligations.
Strategy Inc director sells $286,280 in stock
Strategy Inc director Jarrod Patten sold 1,500 shares for $286,280. Stock down nearly 60% in a year. Details on Bond.az.
How Bond.az spotted Prestige Healthcare's 46% drop
Bond.az's Fair Value models predicted Prestige Healthcare's 46% stock drop. Discover how systematic valuation analysis can identify overvalued stocks before major declines.
Corvex, director Keith Meister buy $13.7m GeneDx stock
GeneDx Holdings Corp. director Keith Meister and Corvex Management LP buy $13.7 million in company stock amid near 52-week low.
Prestige Brands Price Target Cut to $72 by Canaccord
Canaccord cuts Prestige Brands price target to $72 after sales miss. Despite challenges, the company eyes growth through acquisitions.
Canaccord Reaffirms GH Research Stock Rating on Phase 3 Progress
Canaccord Genuity keeps Buy rating on GH Research stock as Phase 3 program for GH001 advances. Key financial highlights included.
Canaccord cuts Sangoma stock rating
Canaccord downgrades Sangoma stock rating due to weak results and pricing pressure. Price target cut to $4.
...